Septerna, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2022-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.septerna.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 1
1 (50.0%)A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers
Not Applicable
Not yet recruiting
- Conditions
- Healthy Volunteers
- Interventions
- Other: Placebo
- First Posted Date
- 2025-07-16
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Septerna, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT07069036
News
No news found